Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-080552
Filing Date
2020-07-02
Accepted
2020-07-02 16:13:40
Documents
1
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5643
  Complete submission text file 0001104659-20-080552.txt   7039
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Beetham Thomas W. (Reporting) CIK: 0001741382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 201009466